Alan Fuhrman Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Alan Fuhrman.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Alan Fuhrman. Alan Fuhrman is a Senior Vice President & CFO in ONCOGENEX PHARMACEUTICALS, INC. ($OGXI) and a Director in Esperion Therapeutics, Inc. ($ESPR) and a Chief Financial Officer in Mirna Therapeutics, Inc. ($MIRN) and a Director in Loxo Oncology, Inc. ($LOXO) and a Director in SpringWorks Therapeutics, Inc. ($SWTX).
Address: SONUS PHARMACEUTICALS, INC. 22026 20TH AVE. SE BOTHELL 98021 WA
Companies in which Alan Fuhrman is an Insider
ACHIEVE LIFE SCIENCES, INC.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of Alan Fuhrman: Senior Vice President & CFO
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 03 2007
$ACHV Market Capitalization: $18.31M
$ACHV Previous Close: $0.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Esperion Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alan Fuhrman: Director
Holdings: 12,878 shares
Current Value: $227,425
Latest Transaction: May 29 2020
$ESPR Market Capitalization: $454.22M
$ESPR Previous Close: $17.66
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Loxo Oncology, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alan Fuhrman: Director
Holdings: 2,625 shares
Current Value: $104,213
Latest Transaction: Feb 15 2019
$LOXO Market Capitalization: $860.18M
$LOXO Previous Close: $39.70
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SpringWorks Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Alan Fuhrman: Director
Holdings: 0 shares
Latest Transaction: May 22 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNLOGIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Alan Fuhrman: Chief Financial Officer
Holdings: 0 shares
Current Value: $0
Latest Transaction: Mar 14 2016
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Alan Fuhrman
Sentiment: All, ACHV, ESPR, LOXO, SWTX, SYBX
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 29 2020 | ESPR | Esperion Therapeut ... | Fuhrman Alan | Director | Grant | A | 0.00 | 1,221 | 0 | 12,878 | 11.7 K to 12.9 K (+10.47 %) |
| May 22 2020 | SWTX | SpringWorks Therap ... | Fuhrman Alan | Director | Option Exercise | A | 38.03 | 7,464 | 283,856 | 7,464 | |
| May 18 2020 | ESPR | Esperion Therapeut ... | Fuhrman Alan | Director | Grant | A | 0.00 | 11,003 | 0 | 11,657 | 654 to 11.7 K (+1,682.42 %) |
| Sep 16 2019 | SWTX | SpringWorks Therap ... | Fuhrman Alan | Director | Option Exercise | A | 18.00 | 29,983 | 539,694 | 29,983 | |
| Sep 16 2019 | SWTX | SpringWorks Therap ... | Fuhrman Alan | Director | Option Exercise | A | 18.00 | 29,983 | 539,694 | 29,983 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 180.98 | 8,750 | 1,583,575 | 0 | |
| Feb 15 2019 | LOXO | Loxo Oncology, Inc ... | Fuhrman Alan | Director | Option Exercise | D | 78.58 | 11,000 | 864,380 | 0 |